Correlation Between Twist Bioscience and Editas Medicine

Can any of the company-specific risk be diversified away by investing in both Twist Bioscience and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Twist Bioscience and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Twist Bioscience Corp and Editas Medicine, you can compare the effects of market volatilities on Twist Bioscience and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Twist Bioscience with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Twist Bioscience and Editas Medicine.

Diversification Opportunities for Twist Bioscience and Editas Medicine

-0.34

Correlation Coefficient

Twist Bioscience  Editas Medicine

Very good diversification

The 3 months correlation between Twist and Editas is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Twist Bioscience Corp and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Twist Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Twist Bioscience Corp are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Twist Bioscience i.e., Twist Bioscience and Editas Medicine go up and down completely randomly.

Pair Corralation between Twist Bioscience and Editas Medicine

Given the investment horizon of 90 days Twist Bioscience Corp is expected to under-perform the Editas Medicine. But the stock apears to be less risky and, when comparing its historical volatility, Twist Bioscience Corp is 3.53 times less risky than Editas Medicine. The stock trades about -0.02 of its potential returns per unit of risk. The Editas Medicine is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  123.00  in Editas Medicine on December 25, 2024 and sell it today you would earn a total of  16.00  from holding Editas Medicine or generate 13.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Twist Bioscience Corp  vs.  Editas Medicine

Twist Bioscience Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Twist Bioscience Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Twist Bioscience is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Editas Medicine

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Editas Medicine are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating forward indicators, Editas Medicine unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Twist Bioscience and Editas Medicine

The main advantage of trading using opposite Twist Bioscience and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Twist Bioscience position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.

The idea behind Twist Bioscience Corp and Editas Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.